These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 12165283

  • 1. Treatment of deep venous thrombosis with low-molecular-weight heparin during pregnancy.
    Ulander VM, Stenqvist P, Kaaja R.
    Thromb Res; 2002 Apr 01; 106(1):13-7. PubMed ID: 12165283
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of an optimal dose of low-molecular-weight heparin for thromboprophylaxis in pregnant women at risk of thrombosis using coagulation activation markers.
    Bombeli T, Raddatz Mueller P, Fehr J.
    Haemostasis; 2001 Apr 01; 31(2):90-8. PubMed ID: 11684864
    [Abstract] [Full Text] [Related]

  • 3. Thromboprophylaxis with low molecular weight heparin (dalteparin) in pregnancy.
    Pettilä V, Kaaja R, Leinonen P, Ekblad U, Kataja M, Ikkala E.
    Thromb Res; 1999 Nov 15; 96(4):275-82. PubMed ID: 10593430
    [Abstract] [Full Text] [Related]

  • 4. Assessment of outpatient treatment of deep-vein thrombosis with low-molecular-weight heparin.
    Harrison L, McGinnis J, Crowther M, Ginsberg J, Hirsh J.
    Arch Intern Med; 1998 Oct 12; 158(18):2001-3. PubMed ID: 9778199
    [Abstract] [Full Text] [Related]

  • 5. Low-molecular-weight heparins for the treatment of deep-vein thrombosis.
    Cziraky MJ, Spinler SA.
    Clin Pharm; 1993 Dec 12; 12(12):892-9. PubMed ID: 8137606
    [Abstract] [Full Text] [Related]

  • 6. Comparative effectiveness of unfractionated and low-molecular-weight heparin for prevention of venous thromboembolism following bariatric surgery.
    Birkmeyer NJ, Finks JF, Carlin AM, Chengelis DL, Krause KR, Hawasli AA, Genaw JA, English WJ, Schram JL, Birkmeyer JD, Michigan Bariatric Surgery Collaborative.
    Arch Surg; 2012 Nov 12; 147(11):994-8. PubMed ID: 23165612
    [Abstract] [Full Text] [Related]

  • 7. Pregnancy after catheter-directed thrombolysis for acute iliofemoral deep venous thrombosis.
    Jørgensen M, Broholm R, Bækgaard N.
    Phlebology; 2013 Mar 12; 28 Suppl 1():34-8. PubMed ID: 23482532
    [Abstract] [Full Text] [Related]

  • 8. Low-molecular-weight heparin (dalteparin) in women with gynecologic malignancy.
    DeBernardo RL, Perkins RB, Littell RD, Krasner CN, Duska LR.
    Obstet Gynecol; 2005 May 12; 105(5 Pt 1):1006-11. PubMed ID: 15863537
    [Abstract] [Full Text] [Related]

  • 9. Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis. EASTERN Investigators.
    Harenberg J, Schmidt JA, Koppenhagen K, Tolle A, Huisman MV, Büller HR.
    Thromb Haemost; 2000 May 12; 83(5):652-6. PubMed ID: 10823256
    [Abstract] [Full Text] [Related]

  • 10. Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin.
    Pettilä V, Leinonen P, Markkola A, Hiilesmaa V, Kaaja R.
    Thromb Haemost; 2002 Feb 12; 87(2):182-6. PubMed ID: 11858475
    [Abstract] [Full Text] [Related]

  • 11. Fixed-dose, body weight-independent subcutaneous low molecular weight heparin Certoparin compared with adjusted-dose intravenous unfractionated heparin in patients with proximal deep venous thrombosis.
    Riess H, Koppenhagen K, Tolle A, Kemkes-Matthes B, Gräve M, Patek F, Drexler M, Siemens HJ, Harenberg J, Weidinger G, Brom J, Haas S, TH-4 Study Group.
    Thromb Haemost; 2003 Aug 12; 90(2):252-9. PubMed ID: 12888872
    [Abstract] [Full Text] [Related]

  • 12. Should patients with deep vein thrombosis alone be treated as those with concomitant asymptomatic pulmonary embolism? A prospective study.
    Monreal M, Büller H, Lensing AW, Bonet M, Roncales J, Muchart J, Fraile M.
    Thromb Haemost; 2002 Dec 12; 88(6):938-42. PubMed ID: 12529742
    [Abstract] [Full Text] [Related]

  • 13. Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin.
    Monreal M, Lafoz E, Olive A, del Rio L, Vedia C.
    Thromb Haemost; 1994 Jan 12; 71(1):7-11. PubMed ID: 8165649
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Once-daily subcutaneous dalteparin, a low molecular weight heparin, for the initial treatment of acute deep vein thrombosis.
    Fiessinger JN, Lopez-Fernandez M, Gatterer E, Granqvist S, Kher A, Olsson CG, Söderberg K.
    Thromb Haemost; 1996 Aug 12; 76(2):195-9. PubMed ID: 8865530
    [Abstract] [Full Text] [Related]

  • 16. Prevention of recurrences after deep venous thrombosis: role of low-molecular-weight heparins.
    Pini M.
    Semin Thromb Hemost; 1997 Aug 12; 23(1):51-4. PubMed ID: 9156411
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Home therapy with LMWH in deep vein thrombosis: randomized study comparing single and double daily administrations.
    Bellosta R, Ferrari P, Luzzani L, Carugati C, Cossu L, Talarico M, Sarcina A.
    Angiology; 2007 Aug 12; 58(3):316-22. PubMed ID: 17626986
    [Abstract] [Full Text] [Related]

  • 19. The acute management of venous thromboembolism in pregnancy.
    Greer IA.
    Curr Opin Obstet Gynecol; 2001 Dec 12; 13(6):569-75. PubMed ID: 11707659
    [Abstract] [Full Text] [Related]

  • 20. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials.
    Gould MK, Dembitzer AD, Doyle RL, Hastie TJ, Garber AM.
    Ann Intern Med; 1999 May 18; 130(10):800-9. PubMed ID: 10366369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.